Skip to search formSkip to main contentSkip to account menu

refractory hairy cell leukemia

Known as: Hairy Cell Leukemia, Refractory, leukemia, hairy cell, recurrent, recurrent hairy cell leukemia 
Hairy cell leukemia that is resistant to treatment.
National Institutes of Health

Related topics

Related topics

18 relations
Atypical lymphocyteB lymphoblastB-LymphocytesBRAF gene
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
This is a pivotal, multicenter, open-label study of moxetumomab pasudotox, a recombinant CD22-targeting immunotoxin, in hairy… 
2017
2017
Ibrutinib for relapsed refractory hairy cell leukemia variant
The variant form of hairy cell leukemia (vHCL) is a rare chronic B-cell malignancy classified separately from classic hairy cell… 
Highly Cited
2013
Highly Cited
2013
Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia
Purpose: To determine tolerability and for the first time explore efficacy of bendamustine–rituximab (BR) in multiply relapsed… 
2013
2013
Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis
Dear Editor, Hairy-cell leukemia (HCL) is a rare hematological malignancy, which typically responds very well to first-line… 
Highly Cited
2013
Highly Cited
2013
Major Cancer Regressions in Mesothelioma After Treatment with an Anti-Mesothelin Immunotoxin and Immune Suppression
In patients with advanced chemotherapy-refractory mesothelioma, treatment with the anti-mesothelin immunotoxin SS1P and… 
2012
2012
Fludarabine and rituximab for relapsed or refractory hairy cell leukemia.
The purine analogs, pentostatin and cladribine, induce high remission rates when used as first-line monotherapy for hairy cell… 
2007
2007
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
The purine analogs pentostatin and cladribine have revolutionized the treatment of hairy cell leukemia (HCL) with overall… 
Highly Cited
2003
Highly Cited
2003
Rituximab in relapsed or refractory hairy cell leukemia.
The purpose of this study was to investigate the efficacy and safety of the monoclonal antibody, rituximab, in relapsed or… 
Highly Cited
1999
Highly Cited
1999
Responses in refractory hairy cell leukemia to a recombinant immunotoxin.
We report major responses in 4 of 4 patients with hairy cell leukemia (HCL) who have recently been treated on a phase I trial… 
1991
1991
Fludarabine phosphate in refractory hairy cell leukemia
Our experience suggests a potential role of fludarabine phosphate in the management of hairy cell leukemia. On the basis of this… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License